image
Vaxart, Inc. VXRT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.5801
-7.92 %
$ 132 M
Market Cap
-1.29
P/E
INCOME STATEMENT
7.38 M REVENUE
6796.26%
Growth Rates
1Year 6796.26%
3Years 22.18%
5Years 12.15%
7Years -2.64%
10Years -20.00%
-83.3 M OPERATING INCOME
27.26%
Growth Rates
1Year 27.26%
3Years -40.32%
5Years -30.82%
7Years -17.16%
10Years -21.90%
-82.5 M NET INCOME
23.47%
Growth Rates
1Year 23.47%
3Years -36.79%
5Years -35.57%
7Years -15.87%
10Years -22.32%
EFFICIENCY
Earnings Waterfall Vaxart, Inc.
image
Revenue 7.38 M
Cost Of Revenue 68.1 M
Gross Profit -60.8 M
Operating Expenses 90.7 M
Operating Income -83.3 M
Other Expenses -882 K
Net Income -82.5 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Jun-2017 Jun-2016 Jun-2015 Jun-2014 Jun-2013 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995 Dec-1994 Dec-1993 Dec-1992 Dec-1991 Dec-1990 Dec-1989 Dec-1988 Dec-1987 Dec-1986 Dec-1985
REVENUE
Revenue 7.4 0.1 0.9 4.0 9.9 4.2 5.8 8.9 9.3 24.6 68.7 33.6 14.8 35.0 10.5 0 0 89.9 108.1 142.2 176.6 196.0 234.8 228.8 233.6 243.1 228.7 239.9 202.0 164.7 101.6 82.4 68.2 72.8 59.2 47.3 43.1 43.7 34.2
GROSS PROFIT
Cost Of Revenue 68.1 3.3 48.7 19.9 14.5 17.3 12.4 17.6 100 K 3.6 51.1 19.7 1.5 4.0 2.0 0 0 62.7 67.2 88.1 81.4 119.9 152.6 152.8 155.2 166.9 173.8 174.0 148.1 130.7 78.8 68.4 57.9 61.6 50.8 41.6 38.0 37.4 29.3
Gross Profit (60.8) (3.2) (47.9) (15.8) (4.7) (13.1) (6.5) (8.7) 9.2 21.0 17.6 13.9 13.4 31.1 8.5 0 0 27.2 40.8 54.1 95.2 76.0 82.2 76.0 78.4 76.2 54.9 65.9 53.9 34.0 22.8 14.0 10.3 11.2 8.4 5.7 5.1 6.3 4.9
OPERATING INCOME
Operating Expenses 90.7 110.4 70.6 35.1 20.7 24.0 83 K 36.3 34.3 29.2 27.7 33.5 23.1 32.3 26.5 25.0 44.9 61.3 122.6 106.2 89.7 60.2 (34.8) 72.4 72.6 77.6 60.6 54.7 63.5 16.6 14.3 12.1 7.0 7.9 6.7 4.3 3.8 4.4 3.3
Selling, General and Administrative Expenses 22.6 29.4 21.9 15.2 6.2 6.7 2.6 5.7 5.6 6.6 6.9 13.6 5.4 6.2 10.0 12.4 26.1 32.6 37.0 46.2 62.3 38.4 52.6 48.3 47.0 44.3 31.6 30.1 56.5 12.2 11.3 9.0 5.8 6.6 5.5 3.6 3.2 3.7 2.7
Research and Development Expenses 68.1 81.1 48.7 19.9 14.5 17.3 12.4 28.3 26.3 19.8 17.5 15.5 17.8 26.1 16.5 12.6 18.8 28.7 57.8 59.6 29.0 21.1 15.3 14.3 15.5 21.8 19.1 16.7 0 0 0 0 0 0 0 0 0 0 0
Operating Income (83.3) (114.6) (72.8) (30.2) (15.8) (21.8) (9.1) (27.5) (25.2) (19.5) (11.5) (22.1) (9.8) (1.2) (18.0) (25.0) (44.9) (61.3) (122.6) (52.0) (12.9) 3.7 117.0 3.6 5.8 (1.4) (5.7) 11.2 (9.6) 17.4 8.5 1.9 3.3 3.3 1.7 1.4 1.3 1.9 1.6
PRE-TAX INCOME
Interest Income Expense 1.4 1.3 1.5 1.9 2.4 2.7 0 1.8 0.3 0 0 0 0 0.2 1.1 3.9 3.5 3.7 3.1 2.2 1.4 2.1 2.1 3.6 0 5.7 0 4.0 1.9 3.0 3.1 2.5 0.6 0.9 1.1 0.5 0 0.5 0.7
Total Other Income 1.1 6.9 2.4 (1.8) (2.4) 3.9 (0.5) (1.7) (0.2) 0.3 0.2 13.3 (2.0) 0.3 (0.8) (0.8) 6.1 7.4 (31.3) 0.9 (0.5) (1.0) (1.0) 0.5 1.8 (14.7) (10.2) (3.2) (1.3) (3.0) (3.1) (1.9) (0.3) (0.3) (0.3) (1.0) (0.3) (0.2) (0.5)
Pre-Tax Income (82.2) (107.7) (70.4) (32.0) (18.2) (17.9) (9.6) (29.1) (25.4) (19.2) (11.3) (8.8) (9.5) (0.9) (18.7) (25.7) (38.8) (60.7) (121.5) (51.2) (13.4) 2.7 116.1 4.1 7.6 (16.1) (15.9) 8.0 (10.9) 14.4 5.4 0 3.0 3.0 1.4 0.4 1.0 1.7 1.1
NET INCOME
Tax Provision 0.3 67 K 0.1 0.2 0.5 0.1 2.9 0.3 0.4 100 K (0.3) 100 K (2.0) (1.8) 1.1 (2.8) (14.3) (0.8) (2.9) 4.7 (6.6) 0.6 11.4 87 K 2.5 20.4 (4.7) (6.2) 6.7 5.8 2.0 2.5 0.8 0.8 0.6 0.2 0.5 0.9 100 K
Net Income (82.5) (107.8) (70.5) (32.2) (18.6) (18.0) (12.5) (29.4) (25.4) (19.1) (11.0) (8.9) (4.5) 0.9 (18.7) (18.7) 47.1 (58.7) (128.4) (50.4) (6.8) 2.1 104.7 4.4 3.3 (21.8) (11.2) 13.3 (17.6) 7.9 3.5 (0.6) 2.2 2.2 0.8 0.2 0.5 0.8 1.0
EPS 0.57 0.84 0.58 0.36 0.86 2.85 91.7 8.37 7.23 5.94 3.86 3.47 7.06 1.32 24.4 23.8 51.5 63.6 142 56.8 9.24 2.64 182 7.92 6.6 41.2 21.1 25.1 34.6 30.4 49.5 2.64 9.24 9.24 3.96 1.32 1.98 3.96 7.26